Inventor · Brussels, BE

Steven De Jonghe

17Patents
7h-index
35Co-inventors
62Inventor score

Filing activity: Aug 27, 2004 → Nov 17, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US7501513B2 Immunosuppressive effects of pteridine derivatives Chemistry; Metallurgy 17 Expired
US8673929B2 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections Chemistry; Metallurgy 16 Active
US8232278B2 Pyrido(3,2-D)pyrimidines and pharmaceutical compositions useful for treating hepatitis C Chemistry; Metallurgy 14 Active
US8338435B2 Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections Human Necessities 12 Active
US9259426B2 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections Chemistry; Metallurgy 10 Active
US8637531B2 Pyrido(3,2-d)pyridmidines useful for treating viral infections Human Necessities 9 Active
US10144736B2 Substituted pteridines useful for the treatment and prevention of viral infections Chemistry; Metallurgy 7 Active
US10882851B2 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections Chemistry; Metallurgy 6 Active
US8901132B2 Thiazolopyrimidine modulators as immunosuppressive agents Chemistry; Metallurgy 4 Active
US9221822B2 Thiazolopyrimidine modulators as immunosuppressive agents Chemistry; Metallurgy 1 Active
US9518066B2 GAK modulators Chemistry; Metallurgy 1 Active
US12049461B2 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections Chemistry; Metallurgy 1 Active
US9193741B2 Antiviral activity of bicyclic heterocycles Emerging Cross-Sectional Technologies 0 Active
US9730944B2 Antiviral activity of novel bicyclic heterocycles Emerging Cross-Sectional Technologies 0 Active
US9822127B2 GAK modulators as antivirals Chemistry; Metallurgy 0 Active
US11040047B2 Prodrugs of nucleoside phosphonates Emerging Cross-Sectional Technologies 0 Active
US10087209B2 Antiviral compounds, a process for their preparation, and their use for treating viral infections Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.